Antihyperglycemic Effect of Andrographolide in Streptozotocin-Induced Diabetic Rats

Abstract

The antihyperglycemic action of andrographolide, an active principle in the leaves of Andrographis paniculata (Burm. f.) Nees, was investigated in streptozotocin-induced diabetic rats (STZ-diabetic rats). Oral treatment of andrographolide decreased the plasma glucose concentrations of STZ-diabetic rats in a dose-dependent manner. Similar treatment with andrographolide also decreased the plasma glucose in normal rats and the maximal effect was more marked than that in STZ-diabetic rats. Andrographolide at the effective dose (1.5 mg/kg) significantly attenuated the increase of plasma glucose induced by an intravenous glucose challenge test in normal rats. In the isolated soleus muscle of STZ-diabetic rats, andrographolide enhanced the uptake of radioactive glucose in a concentration-dependent manner. Moreover, the mRNA and protein levels of the subtype 4 form of the glucose transporter (GLUT4) in soleus muscle were increased after repeated intravenous administration of andrographolide in STZ-diabetic rats for 3 days. These results suggest that andrographolide can increase the glucose utilization to lower plasma glucose in diabetic rats lacking insulin.

Key words

Andrographolide - Andrographis paniculata - Acanthaceae - STZ-diabetic rats - insulin-independent diabetes mellitus

References

• 1 Weidmann P, de Courten M, Boehlen L M. Pathogenesis and treatment of hypertension associated with diabetes mellitus.  Am Heart J. 1993;  125 1498-513
• 2 Trivedi N P, Rawal U M. Hepatoprotective and antioxidant property of Andrographis paniculata (Nees) in BHC induced liver damage in mice.  Indian J Exp Biol. 2001;  39 41-6
• 3 Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G, Wagner H. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human.  Phytomedicine. 2000;  7 351-64
• 4 Zhang X F, Tan B K. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats.  Clin Exp Pharmacol Physiol. 2000;  27 358-63
• 5 Lu X L, Zhang S L, Wang Z S. Analysis of andrographolide compounds. I. Ion pair high performance liquid chromatographic analysis of andrographolide derivatives.  Yao Xue Xue Bao. 1981;  16 182-9
• 6 Maiti P C. Andrographolide: The active principle of Kalmegh.  Bull Bot Surv India. 1964;  6 63-5
• 7 Shen Y C, Chen C F, Chiou W F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect.  Br J Pharmacol. 2002;  135 399-406
• 8 Ahmed M, Talukder S A. Studies on the hypoglycemic activity of Kalmegh (Andrographis paniculata Nees.) on the blood sugar level of rats.  Bangladesh Pharm J. 1977;  6 21-4
• 9 Cheng J T, Liu I M, Chi T C, Su H C, Chang C G. Metformin-like effects of Quei Fu Di Huang Wan, a Chinese herbal mixture, on streptozotocin-induced diabetic rat.  Horm Metab Res. 2001;  33 727-32
• 10 Liu I M, Chi T C, Hsu FL,Chen C F, Cheng J T. Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats.  Planta Med. 1999;  65 712-4
• 11 Liu I M, Hsu F L, Chen C F, Cheng J T. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats.  Br J Pharmacol. 2000;  129 631-6
• 12 Cheng J T, Liu I M, Chi T C, Tzeng T F, Lu F H, Chang C J. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats.  Diabetes. 2001;  50 2815-21
• 13 Baron A D, Brechtel G, Wallace P, Edelman S V. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans.  Am J Physiol. 1988;  255 E769-74
• 14 Ziel F H, Venkatesan N, Davidson M B. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats.  Diabetes. 1988;  37 885-90
• 15 Hollenbeck C, Reaven G M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.  J Clin Endocrinol Metab. 1987;  64 1169-73
• 16 Pessin J E, Bell G I. Mammalian facilitative glucose transporter family: structure and molecular regulation.  Annu Rev Physiol. 1992;  54 911-30
• 17 Berger J, Biswas C, Vicario P P, Strout H V, Saperstein R, Pilch P F. Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting.  Nature. 1989;  340 70-2
• 18 Sivitz W I, Desautel S L, Kayano T, Bell G I, Pessin J E. Regulation of glucose transporter messenger RNA in insulin-deficient states.  Nature. 1989;  340 72-4
• 19 Henriksen E J, Bourey R E, Rodnick K J, KoranyI L, Permutt M A, Holloszy J O. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles.  Am J Physiol. 1990;  259 E593-8